Glomerular abnormalities, in particular mesangial expansion, are frequently found in patients with alcoholic liver disease and these are associated with mesangial deposits of IgA.' 2 They are sometimes but not always associated with clinical manifestations of glomerulonephritis and renal failure.24 The aetiology of these changes is not established but they are often accompanied by high concentrations of IgA in serum.-The latter is present in both monomeric and polymeric forms, and in immune complexes.67 It has been suggested that patients with cirrhosis develop circulating immune complexes as a result of defective hepatic sequestration of gut associated antigens.8 Alternatively, it has been speculated that these complexes may be derived from IgA aggregates combining with liver cell membrane proteins or with Mallory body (MBs) proteins from alcohol damaged liver.9
In this paper two monoclonal antibodies (anti-JMB1 and anti-JMB2) directed 
Results
Of the 11 cases of alcoholic liver disease, eight had cirrhosis and three had severe alcoholic hepatitis (Table 1) . The majority had MBs within hepatocytes detectable on both routine light microscopy and on staining with anti-JMB1 and anti-JMB2. There was a variable degree of fatty infiltration. By light microscopy the kidneys from patients with alcoholic liver disease showed only minor changes. These included mesangial expansion in a few cases and occasional basement membrane thickening. Three cases of alcoholic cirrhosis had extensive deposition of IgA in the mesangium of glomeruli (Fig. 1) Fig. 3 ) and JMB1 to a lesser extent. JMB1 and JMB2 were not fouind in glomerular tufts. In the series of cases of glomerulonephritis unrelated to liver disease, JMB2 was only detected in proliferating epithelial cells of crescentic nephritis (Fig. 4) .
The principal clinical details and causes of death in the alcoholic patients are given in Table 2 . Only one patient (case 2) had clinical evidence of glomerular disease in that he had microscopic haematuria. This patient also had mesangial IgA and JMB2. Three other cases (1, 5 and 8) had impaired renal function with raised plasma urea and creatinine, but at no time was blood or protein found in the urine. Serum IgA was not measured in all patients. Where it was recorded it was raised in two cases (2 and 9). Hepatitis B antigen was not detected in serum of any of the patients.
Discussion
The finding of IgA in glomerular mesangium of almost half the patients with alcoholic cirrhosis is in accord with previous observations, as are the findings on light microscopy and clinical investigation.' 24 The observation that the antigen JMB2 is sometimes present in association with this mesangial IgA raises the possibility that they are present as immune complexes. Proof of such a relation would require elution of antibody from kidney and identification of its specificity; the circumstantial evidence is nevertheless strong. The finding of JMB2 without immunoglobulin in one case of alcoholic hepatitis does not preclude its presence in immune complexes in cirrhosis, since glomerular binding of antigen may precede stimulation of an antibody response.
If JMB2 is indeed involved in immune complex production in cirrhosis, the question arises as to its origin. The most obvious source would be alcohol damaged hepatocytes. JMB2 is a constituent of Mallory bodies and these were present in the majority of cases examined. Circulating alcoholic hyaline and antibody to alcoholic hyaline have been reported previously,'2 although these finding have not been
confirmed. An The possibility that JMB2 is involved in the production of immune complexes in alcoholic cirrhosis may be clinically significant not only because of the potentially damaging effect of the complexes themselves, but also because it provides evidence of an autoimmune response in these patients. Such a reaction may be important in the perpetuation of liver damage initiated by alcohol and in the genesis of renal complications in patients with alcoholic liver disease. 
